Recent Advances in Dynamic Monitoring of Drug Release of Nanoparticle Using Förster Resonance Energy Transfer and Fluorescence Lifetime Imaging

In this review, we summarized the recent advances in dynamic monitoring of drug release of nanoparticle using FRET and FLIM. Using FRET to understanding the dynamics of drug released from its nanocarrier within intracellular milieu provides high sensitivity and temporal information of the releasing...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Chinese Chemical Society (Taipei) Vol. 58; no. 6; pp. 798 - 804
Main Authors Cheng, Shih-Hsun, Chen, Nai-Tzu, Wu, Chia-Yan, Chung, Chao-Yu, Hwu, Yeukuang, Mou, Chung-Yuan, Yang, Chung-Shi, Lo, Leu-Wei
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 01.10.2011
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this review, we summarized the recent advances in dynamic monitoring of drug release of nanoparticle using FRET and FLIM. Using FRET to understanding the dynamics of drug released from its nanocarrier within intracellular milieu provides high sensitivity and temporal information of the releasing profile. Such information is crucial for the design of drug carriers and validation of drug controlled release. This approach thus has been prevailingly used in monitoring of drug release from a variety of DDS, including quantum dot‐, polymer‐, and silica‐based delivery systems. Alternatively, FLIM assessing changes of micro‐environment of drug possesses great potential for use in profiling the intracellular drug release and subcellular drug distribution with various DDS. Our recent approach using FLIM for mapping the intracellular Dox released from pH‐responsive MSN has exemplified the feasibility of delineating subcellular distribution of fluorescent drug with corresponding variation of fluorescence lifetime. Both FRET and FLIM are emerging as important techniques in assessing the efficiency of targeted delivery and controlled release of drug with different nanodelivery systems. In FRET, two types of fluorophores (one for drug‐labeling) are incorporated into the drug‐carrying nanoparticles for use as energy donor and acceptor respectively. Once the nanoparticle carriers become disintegrated upon external stimuli, these fluorophores are discharged from the carrier and diffuse outwards. It consequently increases the average distance between the donors and acceptors, resulting in a decrease of FRET signal.
Bibliography:ark:/67375/WNG-R2NC8L7R-G
ArticleID:JCCS201190124
istex:1B08BA4A7A17F94C76186C73118CD7BBDF1A5AE2
ISSN:0009-4536
2192-6549
DOI:10.1002/jccs.201190124